Duncan W, Orr J A, Arnott S J, Jack W J, Kerr G R
Department of Clinical Oncology, Western General Hospital, Edinburgh, U.K.
Int J Radiat Oncol Biol Phys. 1987 Dec;13(12):1793-6. doi: 10.1016/0360-3016(87)90343-9.
Analyses have been made of the response of metastatic cervical lymph nodes following neutron therapy, either as part of a randomized trial or in patients treated electively. In the trial patients, the overall regression and local control rates were similar after photons and neutrons. Mobile nodes, less than 3.0 cm, appeared to respond better to neutron therapy, and node masses greater than 3.0 cm had better control after photon therapy. The differences observed however were not statistically significant. There was a highly significant association between the control of the primary tumor and control of nodal disease. No survival advantage for neutrons was observed in association with apparently better control rates in cervical nodes.
已经对中子治疗后转移性颈部淋巴结的反应进行了分析,这些分析要么作为随机试验的一部分,要么针对接受选择性治疗的患者。在试验患者中,光子治疗和中子治疗后的总体消退率和局部控制率相似。小于3.0厘米的可移动淋巴结似乎对中子治疗反应更好,而大于3.0厘米的淋巴结肿块在光子治疗后控制效果更好。然而,观察到的差异无统计学意义。原发肿瘤的控制与淋巴结疾病的控制之间存在高度显著的关联。在颈部淋巴结控制率明显更好的情况下,未观察到中子治疗具有生存优势。